⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 15, 2025JAMA

New Molecules and Indications for GLP-1 Medicines

María J. Gonzalez-Rellan Daniel J. Drucker

View at Publisher

Ask AI

Bookmark

Share

Key Points

Recent advancements in novel GLP-1 medicines show promising potential for broader therapeutic applications.
Emerging indications for GLP-1 therapies may enhance their utility in treating diverse metabolic conditions.
This perspective utilizes a comprehensive review of existing literature on GLP-1 medicines to highlight future directions.
Further exploration is needed to validate the efficacy and safety of new GLP-1 molecules in clinical settings.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Implication

This Perspective explores progress in GLP-1 medicines and indicates future developments in therapeutics.

Abstract

This Perspective explores recent progress and future directions in glucagon-like peptide-1 medicines.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Gonzalez-Rellan et al. (2025) studied this question.

synapsesocial.com/papers/68d44f8c31b076d99fa57493 https://doi.org/10.1001/jama.2025.14392

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Innovative molecules and delivery technologies enabling the future of GLP-1-based therapies2025 · 9 citations
2Current Perspectives on GLP-1 Agonists in Contemporary Clinical Practice from Science and Mechanistic Foundations To Optimal Translation2025 · 12 citations
3Glucagon-Like Peptide-1 Based Therapies: A New Horizon in Obesity Management2024 · 33 citations
4Incretin-Based Polypharmacology and the Redefinition of Cardiometabolic Medicinereview · 2026
5Beyond Diabetes: A Review of Emerging Indications for Glucagon-Like Peptide-1 Receptor AgonistsHuman Clinical Trial · 2026

GLP-1 receptor agonism: a transformative approach for managing type-2 diabetes and obesity2025
Emerging Frontiers in GLP-1 Therapeutics: A Comprehensive Evidence Base (2025)2025
The New Biology and Pharmacology of Glucagon2017
Regression Discontinuity Approaches to Evaluate Threshold-Guided Interventions in Observational StudiesJAMA · 2026
Injuries From Electric Bicycles and Scooters Managed in Pediatric Health SystemsJAMA · 2026

More from Mount Sinai Hospital

More from Lunenfeld-Tanenbaum Research Institute